
A third COVID-19 vaccine hits the U.S. market
03/09/21 • 14 min
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the latest vaccine authorized by the Food and Drug Administration (FDA) for emergency use, including:
- Vaccine clinical trials and the efficacy rate on COVID-19 related infections
- Expected uptick in the overall vaccine supply
- Existing COVID-19 vaccines’ effectiveness on COVID-19 variants
- FDA’s updated guidance to address vaccines and emerging COVID-19 variants
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, provide an update on the latest vaccine authorized by the Food and Drug Administration (FDA) for emergency use, including:
- Vaccine clinical trials and the efficacy rate on COVID-19 related infections
- Expected uptick in the overall vaccine supply
- Existing COVID-19 vaccines’ effectiveness on COVID-19 variants
- FDA’s updated guidance to address vaccines and emerging COVID-19 variants
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Previous Episode

Federal agency priorities under the Biden Administration
Tune into this episode of PwC's Next in Health to hear Health Research Institute (HRI) leader, Benjamin Isgur, and HRI Regulatory Center leader, Trine Tsouderos in discussion with HRI's Erin McCallister on what pharma might expect from federal agencies, including:
- Food and Drug Administration (FDA)'s potential to broaden / standardized policies implemented in response to the pandemic (i.e., clinical trial diversity, supply chain visibility)
- How politics has impacted FDA productivity
- Centers for Medicare & Medicaid Services (CMS)' approach to control drug spending
- Health and Human Services' role in 340B changes
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
Next Episode

COVID-19: One year later
Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, reflect on the pandemic’s one year mark and where we are now, including:
- The Advisory Committee on Immunization Practices (ACIP) issues vaccine rollout recommendations and safety guidelines
- Considerations for mRNA COVID-19 vaccines’ dosing intervals
- The Centers for Disease Control and Prevention (CDC)’s V-safe vaccine reporting system
- Learnings from past pandemics
For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/pwcs-next-in-health-214439/a-third-covid-19-vaccine-hits-the-us-market-24019982"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to a third covid-19 vaccine hits the u.s. market on goodpods" style="width: 225px" /> </a>
Copy